Ej. Blom et al., Transforming growth factor-beta 1 incorporated during setting in calcium phosphate cement stimulates bone cell differentiation in vitro, J BIOMED MR, 50(1), 2000, pp. 67-74
Growth stimulation of periimplant tissues by growth factors like transformi
ng growth factor-beta 1 (TGF-beta 1) may increase the indication for and su
ccess of implant use. Calcium phosphate as a material for implants or for c
oating of implants is known for its good biologic interaction with bone. Th
erefore, calcium phosphate implants combined with TGF-beta 1 might improve
osseointegration. In this study we hypothesise that the addition of recombi
nant human TGF-beta 1 (rhTGF-beta 1) to calcium phosphate cement (CPC) affe
cts the differentiation of bone cells growing on the cement laver. rhTGF-be
ta 1 incorporated during settings in a CPC layer at 20 ng rhTGF-beta 1/60 m
g cement was found to be gradually released into tissue culturing medium le
ading to a 20% release after 24 h. Two cell populations were obtained from
collagenase-treated fragments of adult rat long hones: preosteoblastic cell
s, which were released by the collagenase treatment, and osteoblastic cells
, which grew from the collagenase-stripped bone fragments. Both cell popula
tions were tested for their osteoblastic characteristic phenotype by measur
ing their alkaline phosphatase (ALP) activity after vitamin D treatment and
cyclic AMP after parathyroid hormone stimulation. After preculture the cel
ls were plated on a layer of CPC containing 0 (control), 10, or 20 ng rhTGF
-beta 1/60 mg CPC. Bone cell differentiation was analyzed after 10 days by
measuring the ALP activity, as well as the protein content of the cell laye
r. Incorporation of rhTGF-beta 1 in the CPC did not change the ALP activity
in osteoblastic cells, but a significant (analyzed by multivariate analysi
s of variance) increase was observed in preosteoblastic cells. Incorporatio
n of 10 ng of rhTGF-beta 1 in 60 mg of CPC increased the ALP activity in pr
eosteoblastic cells by threefold and 20 ng rhTGF-beta 1/60 mg CPC increased
it by fivefold. The total protein content was not affected by rhTGF-beta 1
in either of the cell populations. We conclude that rhTGF-beta 1 incorpora
ted during setting in CPC stimulates the differentiation of pre-osteoblasti
c cells in vitro. These results provide a basis for further studies on the
use of this combination as an implant material in vitro. (C) 2000 John Wile
y & Sons, Inc.